Randomised, controlled, double-blind trial of Chinese Herbal Medicine as adjuvant treatment in patients with Crohn's disease
Completed
- Conditions
- Crohn's diseaseDigestive SystemCrohn's disease [regional enteritis]
- Registration Number
- ISRCTN69696725
- Lead Sponsor
- Friedrich-Alexander-University of Erlangen-Nuremberg (Germany)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1. 60 participants
2. Disease duration greater than 1 year
3. Crohn's Disease Activity Index (CDAI) 150 - 450
4. Aged 18 - 60 years
Exclusion Criteria
Not provided at time of registration.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method